PROFILING OF ACTIONABLE ALTERATIONS IN LUNG ADENOCARCINOMA

被引：0
|
作者：
Prabhash, Kumar [1 ]
Chandrani, Pratik [2 ]
Aich, Jyotirmoi [2 ]
Upadhyay, Pawan [2 ]
Chougule, Anuradha [1 ]
Noronha, Vanita [1 ]
Joshi, Amit [1 ]
Desai, Saral [1 ]
Jambekar, Nirmala [1 ]
Thavamani, Abhishek [2 ]
Jose, Tony [3 ]
Chandna, Puneet [4 ]
Dutt, Amit [5 ]
机构：
[1] Tata Mem Hosp, Kolkata, India
[2] Actrec, Navi Mumbai, Maharashtra, India
[3] Sandor Prote Pvt Ltd, Hyderabad, Andhra Pradesh, India
[4] Aceprobe Technol Pvt Ltd, New Delhi, India
[5] Actrec, Dutt Lab, Navi Mumbai, Maharashtra, India
来源：
JOURNAL OF THORACIC ONCOLOGY | 2013年 / 8卷
关键词：
molecular profiling; lung cancer;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P3.18-019
引用
收藏
页码：S1261 / S1261
页数：1
相关论文
共 50 条
  • [1] Discovery of actionable alterations in lung adenocarcinoma
    Chandrani, P.
    Prasad, R.
    Chougule, A.
    Sethunath, V.
    Aich, J.
    Dhamne, H.
    Upadhyay, P.
    Iyer, D. N.
    Thavamani, A.
    Mohanty, B.
    Thorat, R.
    Chaudhari, P.
    Sindhi, R.
    Chandna, P.
    Prabhash, K.
    Dutt, A.
    EUROPEAN JOURNAL OF CANCER, 2016, 54 : S55 - S56
  • [2] Mutations of DNA Damage Repair Genes in Lung Adenocarcinoma and Their Association with Actionable Alterations
    Yu, Z.
    Dang, S.
    Zhang, J.
    Duan, J.
    Chen, S.
    Yang, J.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (03) : S534 - S535
  • [3] Histological characteristics of lung adenocarcinoma with uncommon actionable alterations: special emphasis on MET exon 14 skipping alterations
    Hayashi, Takuo
    Kohsaka, Shinji
    Takamochi, Kazuya
    Kishikawa, Satsuki
    Ikarashi, Daiki
    Sano, Kei
    Hara, Kieko
    Onagi, Hiroko
    Suehara, Yoshiyuki
    Takahashi, Fumiyuki
    Saito, Tsuyoshi
    Nakatsura, Tetsuya
    Kitano, Shigehisa
    Suzuki, Kenji
    Yao, Takashi
    HISTOPATHOLOGY, 2021, 78 (07) : 987 - 999
  • [4] Comprehensive Analysis of Genomic Alterations in Hepatoid Adenocarcinoma of the Stomach and Identification of Clinically Actionable Alterations
    Zhao, Rongjie
    Li, Hongshen
    Ge, Weiting
    Zhu, Xiuming
    Zhu, Liang
    Wan, Xiangbo
    Wang, Guanglan
    Pan, Hongming
    Lu, Jie
    Han, Weidong
    CANCERS, 2022, 14 (16)
  • [5] The landscape of actionable genomic alterations in lung adenocarcinomas in India
    Sharma, Rakesh
    Kamireddy, Aruna Priya
    Hussaini, Syed Meera
    Chatterjee, Soma
    Hasan, Qurratulain
    Jain, Jugnu
    FRONTIERS IN GENETICS, 2023, 14
  • [6] Rare Actionable Mutations in a Lung Adenocarcinoma Cohort in Brazil
    Ferreira, C. G.
    Zalis, M.
    Reis, M.
    Schluckebier, L.
    Montella, T.
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S2388 - S2389
  • [7] Precision medicine and actionable alterations in lung cancer.
    Mambetsariev, Isa
    Nadaf, Sorena
    Wang, Yingyu
    Chen, Chen
    Hewelt, Blake
    Pharaon, Rebecca
    Massarelli, Erminia
    Koczywas, Marianna
    Reckamp, Karen L.
    Salgia, Ravi
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [8] Genomic alterations in lung adenocarcinoma
    Devarakonda, Siddhartha
    Morgensztern, Daniel
    Govindan, Ramaswamy
    LANCET ONCOLOGY, 2015, 16 (07): : E342 - E351
  • [9] Alterations in cell cycle genes in early stage lung adenocarcinoma identified by expression profiling
    Singhal, S
    Amin, KM
    Kruklitis, R
    DeLong, P
    Friscia, ME
    Litzky, LA
    Putt, ME
    Kaiser, LR
    Albelda, SM
    CANCER BIOLOGY & THERAPY, 2003, 2 (03) : 291 - 298
  • [10] METABOLOMIC PROFILING OF LUNG ADENOCARCINOMA
    Hoang, C. D.
    Wu, M.
    Xu, Y.
    Peltz, G.
    Merritt, R.
    Whyte, R.
    Shrager, J.
    JOURNAL OF THORACIC ONCOLOGY, 2010, 5 (05) : S51 - S52
12345